skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

GlycoMantra published a paper in Oncotarget

October 20, 2017 GlycoMantra published a paper in Oncotarget Studies suggest that tunicamycin may work…

read more

GlycoMantra received STTR grant from the NCI (NIH)

September 07, 2017 GlycoMantra received STTR grant from the NCI (NIH). With the University of…

read more

GlycoMantra received Investor Initiative Award from the NCI (NIH).

July 2017 GlycoMantra received Investor Initiative Award from the NCI (NIH).   Through this mechanism,…

read more

GlycoMantra published a paper on nanomagnetolectin induced cancer cell death

Magnetic nanoparticles represent a new paradigm for molecular targeting therapy in cancer. However, the transformative…

read more
Back To Top